Michael Carducci, MD

Michael Carducci, MD

Oncology Baltimore, MD

Professor of Oncology, Professor of Urology, Johns Hopkins University School of Medicine; AEGON Professor of Prostate Cancer Research, Co-Director, Prostate Cancer/GU Oncology Program, Co-Director, Chemical Therapeutics


Office Address

  • 600 N Wolfe St
    Baltimore, MD 21287
    Phone: (410) 955-8964

Are you Dr. Carducci?

Claim your profile and join over 50% of U.S. physicians already on Doximity.

Claim this pageNo, this isn't me

Michael Carducci, MD

Oncology Baltimore, MD

Professor of Oncology, Professor of Urology, Johns Hopkins University School of Medicine; AEGON Professor of Prostate Cancer Research, Co-Director, Prostate Cancer/GU Oncology Program, Co-Director, Chemical Therapeutics

56 Colleague InvitesIs this you? Register Now to see 56 messages.

Summary

  • Dr. Michael Carducci, MD is a board certified oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and District of Columbia. He is affiliated with Johns Hopkins Hospital and is a Professor of Medicine at Johns Hopkins University

Clinical Specialties & Interests

  • Oncology: General Oncology

Education & Training

  • Johns Hopkins UniversityJohns Hopkins University
  • University of ColoradoUniversity of Colorado
  • Wayne State University School of MedicineWayne State University School of Medicine

Certifications & Licensure

  • DC State Medical LicenseDC State Medical License2012 - 2016
  • MD State Medical LicenseMD State Medical License1992 - 2016
  • American Board of Internal MedicineMedical Oncology
  • American Board of Internal MedicineInternal Medicine

    Awards, Honors, & Recognition

    • CMS Meaningful Use Stage 1 CertificationEpicCare Ambulatory EMR, Epic Systems Corporation, 2013

    Clinical Trials

    Publications & Presentations

    PubMed

    Grant Support

    • Phase I Clinical Trials Of New Anti-Cancer Targeted TherapiesNational Cancer Institute
      2008 - 2012
    • Foreign Accrual For U01ca70095 - 2006 Load.National Cancer Institute
      2006 - 2006
    • DSMNational Cancer Institute
      2006 - 2010
    • Phase I Clinical Trials Of New Anti-Cancer Targeted TherNational Cancer Institute
      2003 - 2007
    • Restoration Of Gene Function In Prostate CancerNational Cancer Institute
      2003 - 2003
    • Phase I Trials Of Anticancer AgentsNational Cancer Institute
      2001 - 2002
    • Dose/Pharmacokinetics Of ABT 627 In AdenocarcinomaNational Center For Research Resources
      2000 - 2002
    • Phase I Trial Of Oral Phenylbutyrate In Solid TumorsNational Center For Research Resources
      2000 - 2002
    • A Randomized Controlled Phase II Clinical Trial Of ModulDivision Of Cancer Prevention And Control
      1999 - 2000
    • Multiple Dose Study Of Safety Of ABT 627National Center For Research Resources
      1998 - 2002
    • Phenylbutyrate Bioactivity Assessment In Prostate CancerNational Cancer Institute
      1997 - 2000
    • Continuous Infusion Phenylbutyrate Given For 120 HRS Every 21 DaysNational Center For Research Resources
      1997 - 1997
    • Gene Therapy For Prostate CancerNational Cancer Institute
      1996 - 2000

    Hospital Affiliations

    Insurance Accepted

    • BCBS Blue Card PPO
    • CareFirst BCBS Maryland POS
    • CareFirst BlueChoice Advantage
    • CareFirst BlueChoice Network POS
    • CareFirst BluePreferred PPO
    • CIGNA HMO
    • CIGNA Open Access
    • CIGNA PPO
    • First Health PPO
    • Great West PPO
    • Humana ChoiceCare Network PPO
    • Multiplan PHCS PPO
    • Multiplan PPO
    • United Healthcare - Direct Choice Plus POS
    • United Healthcare - Direct Options PPO

    Alternate Names

    • Dr. Michael Carducci, Dr. Michael Carducci, MD, Dr. M Carducci, Dr. Michael Anthony Carducci

    Physicians, view Dr. Carducci's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV